ES2038663T3 - Un metodo para preparar una composicion para la aplicacion por via topica, destinada al tratamiento de la enfermedad epitelial hiperproliferativa. - Google Patents

Un metodo para preparar una composicion para la aplicacion por via topica, destinada al tratamiento de la enfermedad epitelial hiperproliferativa.

Info

Publication number
ES2038663T3
ES2038663T3 ES198787304797T ES87304797T ES2038663T3 ES 2038663 T3 ES2038663 T3 ES 2038663T3 ES 198787304797 T ES198787304797 T ES 198787304797T ES 87304797 T ES87304797 T ES 87304797T ES 2038663 T3 ES2038663 T3 ES 2038663T3
Authority
ES
Spain
Prior art keywords
treatment
preparing
composition
intended
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787304797T
Other languages
English (en)
Inventor
Gerald D. Weinstein
Jerry L. Mccullough
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California San Diego UCSD
Original Assignee
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California San Diego UCSD filed Critical University of California San Diego UCSD
Application granted granted Critical
Publication of ES2038663T3 publication Critical patent/ES2038663T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSICIONES TOPICAS QUE CONTIENEN METOTREXATO O SUS ANALOGOS Y UN AGENTE DE PENETRACION EN LA PIEL EFICAZ, ASI COMO METODOS PARA SU USO EN EL TRATAMIENTO TOPICO DE ENFERMEDADES EPITELIALES HIPERPROLIFERATIVAS, TALES COMO PSORIASIS.
ES198787304797T 1986-05-30 1987-05-29 Un metodo para preparar una composicion para la aplicacion por via topica, destinada al tratamiento de la enfermedad epitelial hiperproliferativa. Expired - Lifetime ES2038663T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86893686A 1986-05-30 1986-05-30

Publications (1)

Publication Number Publication Date
ES2038663T3 true ES2038663T3 (es) 1993-08-01

Family

ID=25352598

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787304797T Expired - Lifetime ES2038663T3 (es) 1986-05-30 1987-05-29 Un metodo para preparar una composicion para la aplicacion por via topica, destinada al tratamiento de la enfermedad epitelial hiperproliferativa.

Country Status (9)

Country Link
EP (1) EP0247900B1 (es)
JP (1) JPS6327432A (es)
AT (1) ATE70444T1 (es)
CA (1) CA1300508C (es)
DE (1) DE3775278D1 (es)
DK (1) DK277387A (es)
ES (1) ES2038663T3 (es)
NZ (1) NZ220495A (es)
ZA (1) ZA873928B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2808492A (en) * 1991-10-26 1993-05-21 East Riding Laboratories Limited Medicament composition for topical application
AU5495798A (en) * 1997-01-16 1998-08-07 Sekisui Chemical Co., Ltd. External preparations for percutaneous absorption
KR100439204B1 (ko) * 2000-10-25 2004-07-07 주식회사 삼양사 메토트렉세이트를 유효성분으로 함유하는 경피투여용 조성물
BR102012009350B1 (pt) * 2012-04-20 2020-12-29 Biolab Sanus Farmacêutica Ltda composição farmacêutica tópica, processo de produção da composição farmacêutica tópica e uso da composição farmacêutica tópica
US20210186862A1 (en) * 2017-12-05 2021-06-24 Shilpa Medicare Ltd Methotrexate topical solution for treatment of psoriasis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1553310A (en) * 1975-06-19 1979-09-26 Nelson Res & Dev Vehicle composition containing 1-substituted azacycloalkan-2-ones
GB2143433A (en) * 1983-06-20 1985-02-13 Hariprasad Manibhai Patel Methotrexate ointment
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4743588A (en) * 1984-06-13 1988-05-10 Allergan Pharmaceuticals, Inc. Compositions and methods of enhancing transdermal and transmembrane penetration systemic agents

Also Published As

Publication number Publication date
DK277387A (da) 1987-12-01
ZA873928B (en) 1988-02-24
EP0247900B1 (en) 1991-12-18
JPS6327432A (ja) 1988-02-05
DK277387D0 (da) 1987-05-29
NZ220495A (en) 1990-07-26
EP0247900A1 (en) 1987-12-02
ATE70444T1 (de) 1992-01-15
CA1300508C (en) 1992-05-12
DE3775278D1 (de) 1992-01-30

Similar Documents

Publication Publication Date Title
ES2173978T3 (es) Utilizacion de un alcohol graso insaturado.
ES8301624A1 (es) Un metodo para la preparacion de una composicion de cal sulfurada, util en el tratamiento de la piel.
ES2052881T3 (es) Agentes reductores de la presion sanguinea.
ES2126766T3 (es) 7-azaindol-3-ilcarboxiamidas de tropilo como agente antitusivo.
PT83933B (pt) Processo para a preparacao de composicoes estaveis de activador do plasminogenio humano, tipo tecido
NZ314839A (en) 1,25-Dihydroxy-16,23Z-diene-20-epi-16-ene-cholecalciferol (Vitamin D3) analogues
ES2042564T3 (es) Composiciones por via topica penetrantes mejoradas para aumentar el crecimiento del cabello.
BR8704413A (pt) Processo para a fabricacao de bastoes desodorantes transparentes
AR018357A1 (es) Acido petroselinico en una composicion y en un metodo para reducir o eliminar la irritacion o la picazon de la piel inducida por los alfa-hidroxiacidos
ZA796356B (en) New hydroxypropyl-triazole compounds, their production and their medicinal use
BRPI0017528B8 (pt) uso de uma composição contendo sal de cetotifeno
ES507810A0 (es) Procedimiento para hidroformilar compuestos olefinicamente insaturados.
BR9915955A (pt) Composição cosmética para cuidado com a pele, processo cosmético para tratar uma pele envelhecida e uso de 4- cromanona
ES2077559T3 (es) Estabilizacion de proteinas terapeuticamente activas en preparados farmaceuticos.
ES2129893T3 (es) Dinucleosido-5',5'-pirofosfatos.
NO962655D0 (no) Deutrerte virkestoffer i transdermal applikasjon
ES2038663T3 (es) Un metodo para preparar una composicion para la aplicacion por via topica, destinada al tratamiento de la enfermedad epitelial hiperproliferativa.
ES2180690T3 (es) Preparacion de composiciones que comprenden st1435 para aplicacion topica.
BR0009194A (pt) Composição do resorcinol
IT1164176B (it) Composizione per un'applicazione topica contenente,come sostanza attiva sull'elasticia',la morbidezza della pelle tiamorfolinone oppure uno dei suoi derivati
ES2101334T3 (es) Utilizacion terapeutica de la fosforil-l-serina-n-acil-esfingosina.
AR022017A1 (es) Un agente para tratar el trastorno de la funcion de las celulas visuales. el metodo de tratamiento y el uso de dicho agente para la produccion de unacomposicion farmaceutica
MX9401172A (es) Derivados fluorados de 4-aminoandrostadienona, procesamiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2196171T3 (es) Agentes antitumorales de tioxantenona liofilizada.
BR9002240A (pt) Processo para a preparacao de uma composicao conservada apropriada para aplicacao topica a pele e composicao

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 247900

Country of ref document: ES